| 44.93 0.04 (0.09%) | 05-22 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 58.91  |
1-year : | 68.81 |
| Resists | First : | 50.43 |
Second : | 58.91 |
| Pivot price | 37.19 |
|||
| Supports | First : | 37.64 |
Second : | 29.73 |
| MAs | MA(5) : | 43.24 |
MA(20) : | 36.49 |
| MA(100) : | 42.73  |
MA(250) : | 38.99 |
|
| MACD | MACD : | 2 |
Signal : | 0.7 |
| %K %D | K(14,3) : | 76.5 |
D(3) : | 79.1 |
| RSI | RSI(14): 65.3 |
|||
| 52-week | High : | 81.55 | Low : | 21.77 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SMLR ] has closed below upper band by 5.7%. Bollinger Bands are 29.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 48.67 - 48.9 | 48.9 - 49.11 |
| Low: | 41.97 - 42.21 | 42.21 - 42.43 |
| Close: | 44.48 - 44.87 | 44.87 - 45.24 |
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
Mon, 19 May 2025
Bitcoin-Linked Semler Scientific Stock Is Trending On Monday: What's Going On? - Strategy (NASDAQ:MSTR) - Benzinga
Mon, 19 May 2025
4th Largest US Bitcoin Holder Semler Scientific Strengthens Crypto Strategy with Key Board Appointment - Stock Titan
Mon, 19 May 2025
Semler Scientific® Appoints Natalie Brunell to its Board of Directors - PR Newswire
Sat, 17 May 2025
Semler Scientific, Inc.'s (NASDAQ:SMLR) 32% Price Boost Is Out Of Tune With Revenues - simplywall.st
Fri, 16 May 2025
Semler Scientific Inc (SMLR) Stock Price Up 17.32% on May 16 - GuruFocus
Fri, 16 May 2025
Wolf Haldenstein Adler Freeman & Herz LLP is investigating - GlobeNewswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 12 (M) |
| Shares Float | 8 (M) |
| Held by Insiders | 12.7 (%) |
| Held by Institutions | 53.1 (%) |
| Shares Short | 1,670 (K) |
| Shares Short P.Month | 1,490 (K) |
| EPS | 5.13 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 24.14 |
| Profit Margin | 72.6 % |
| Operating Margin | 28.5 % |
| Return on Assets (ttm) | 8.2 % |
| Return on Equity (ttm) | 27 % |
| Qtrly Rev. Growth | -17.7 % |
| Gross Profit (p.s.) | 4.44 |
| Sales Per Share | 4.85 |
| EBITDA (p.s.) | 1.82 |
| Qtrly Earnings Growth | 534.5 % |
| Operating Cash Flow | 24 (M) |
| Levered Free Cash Flow | 15 (M) |
| PE Ratio | 8.82 |
| PEG Ratio | 0 |
| Price to Book value | 1.87 |
| Price to Sales | 9.33 |
| Price to Cash Flow | 21.51 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|